Rebecca Wilson, EVP International, Speaks at AusBiotech 2022
Australia's Life Sciences Conference
Where: Perth Convention and Exhibition Centre, Perth, Australia
When: October 26-28, 2022
AusBiotech, the continent's flagship industry conference, returns in-person for the first time in three years — an opportunity for the biotech community to exchange ideas and propel the industry forward.
Unlocking the Opportunity: Getting Started on Your Company's ESG Journey
When: October 26, 3:30 p.m. - 5:00 p.m. (AWST)
Environmental, Social and Governance (ESG) goals are no longer a “nice to have” for life sciences companies. This panel will explore how to meaningfully integrate ESG into corporate structure and ideology, as well as discuss how acting now can help organizations thrive amid the increasing scrutiny of investors, regulators and public opinion.
Rebecca Wilson, Executive Vice President, International, WE Communications
Michelle Burke, Non-Executive Director, Cell Therapies Pty Ltd (Chair)
Dr. Michael Molinari, Managing Director, IP Group Australia
Steve Yatomi-Clarke, Chief Executive Officer and Managing Director, President Therapeutics
Dr. Arjun Kaushik, Chief Executive Officer, Vital Trace